TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 22, No. 17 September 1, 2016
_________________________________
UPCOMING MEETINGS EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 22, No. 17 September 1, 2016
(The next issue will be on September 15, 2016)
TRIGGER is also available by RSS Feed:
PAPERS IN PRESS
None Submitted for this issue.
_________________________________None Submitted for this issue.
UPCOMING MEETINGS EVENTS
UNRAVELING VASCULAR INFLAMMATION: FROM IMMUNOLOGY TO IMAGING 2016 A symposium on the NIH campus sponsored by the National Heart, Lung & Blood Institute, October 24-25, 2016. Abstract deadline is September 16. For more information:
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
_________________________________
ISTH also maintains a list of upcoming meetings of interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
Antoniak S, Mackman N (2016) Editorial Commentary: Tissue factor expression by the endothelium: Coagulation or inflammation? Trends Cardiovasc Med 26:304-305.
Atas E, Kesik V, Gursel O (2015) Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide. J Cancer Res Ther 11:667.
Bucci M, Tana C, Giamberardino MA, Cipollone F (2016) Lp(a) and cardiovascular risk: Investigating the hidden side of the moon. Nutr Metab Cardiovasc Dis.
Crispel Y, Axelman E, Tatour M, Kogan I, Nevo N, Brenner B, Nadir Y (2016) Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model. Thromb Haemost 116.
De Caterina R, D'Ugo E, Libby P (2016) Inflammation and thrombosis - testing the hypothesis with anti-inflammatory drug trials. Thromb Haemost 116.
Deng C, Wu D, Yang M, Chen Y, Wang C, Zhong Z, . . . Wu S (2016) Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis.
Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF (2016) Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 8:CD010982.
Devlin R, Bonanno L, Badeaux J (2016) The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering from blunt force trauma compared with penetrating trauma: a systematic review. JBI Database System Rev Implement Rep 14:116-138.
Dong R, Chen W, Feng W, Xia C, Hu D, Zhang Y, . . . Tu L (2015) Exogenous Bradykinin Inhibits Tissue Factor Induction and Deep Vein Thrombosis via Activating the eNOS/Phosphoinositide 3-Kinase/Akt Signaling Pathway. Cell Physiol Biochem 37:1592-1606.
Donner J, Kaukonen M, Anderson H, Moller F, Kyostila K, Sankari S, . . . Lohi H (2016) Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders. PLoS One 11:e0161005.
Eisenreich A, Bolbrinker J, Leppert U (2016) Tissue Factor: A Conventional or Alternative Target in Cancer Therapy. Clin Chem 62:563-570.
Etchill E, Sperry J, Zuckerbraun B, Alarcon L, Brown J, Schuster K, . . . Neal MD (2016) The confusion continues: results from an American Association for the Surgery of Trauma survey on massive transfusion practices among United States trauma centers. Transfusion.
Franz C, Boing AN, Montag M, Strowitzki T, Markert UR, Mastenbroek S, . . . Toth B (2016) Extracellular vesicles in human follicular fluid do not promote coagulation. Reprod Biomed Online.
Girish VM, Kini RM (2016) Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus. Sci Rep 6:32036.
Grandone E, Chinni E, Villani M, Scianname N, Tiscia GL, Favuzzi G, . . . Margaglione M (2016) Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. Arch Gynecol Obstet.
Gu J, Gu W, Lin C, Gu H, Wu W, Yin J, . . . Gu X (2015) Human umbilical cord mesenchymal stem cells improve the immune-associated inflammatory and prothrombotic state in collagen type--induced arthritic rats. Mol Med Rep 12:7463-7470.
Hartmann J, Croteau SE (2016) 2016 Clinical Trials Update: Innovations in Hemophilia Therapy. Am J Hematol.
Huang B, Park DW, Baek SH (2016) TRIF is a regulator of TLR2-induced foam cell formation. Mol Med Rep.
Imafuku A, Sawa N, Ubara Y, Takaichi K (2016) Acquired hemophilia A that developed during the induction of hemodialysis: the use of double-filtration plasmapheresis. Clin Nephrol.
Kuperman AA, Brenner B, Kenet G (2015) Intraventricular haemorrhage in preterm infants--can we improve outcome by addressing coagulation? J Matern Fetal Neonatal Med 28 Suppl 1:2265-2267.
Kwon DJ, Kim DH, Hwang IS, Kim DE, Kim HJ, Kim JS, . . . Hwang S (2016) Generation of alpha-1,3-galactosyltransferase knocked-out transgenic cloned pigs with knocked-in five human genes. Transgenic Res.
Kwon JO, MacLaren R (2016) Comparison of Fresh Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study. Pharmacotherapy.
Li S, Tian Y, Zhao Y, Zhang Y, Su S, Wang J, . . . Nie G (2015) pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth. Oncotarget 6:23523-23532.
Liu Y, Zhang L, Wang C, Roy S, Shen J (2016) Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR. J Biol Chem 291:1553-1563.
Matsunari Y, Sugimoto M, Doi M, Matsui H, Kawaguchi M (2016) Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions. Int J Hematol.
Mitchel JA, Antoniak S, Lee JH, Kim SH, McGill M, Kasahara DI, . . . Park JA (2016) IL-13 Augments Compressive Stress-Induced Tissue Factor Expression in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol 54:524-531.
Mitrophanov AY, Szlam F, Sniecinski RM, Levy JH, Reifman J (2016) A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation. Anesth Analg 123:535-546.
Morfini M, Zanon E (2016) Emerging drugs for the treatment of hemophilia A and B. Expert Opin Emerg Drugs:1-13.
Napolitano M, Dolce A, Batorova A, Giansily-Blaizot M, Ingerslev J, Mirbehbahani N, . . . Mariani G (2015) Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery. Haemophilia 21:e513-517.
Nguyen TT, Petersen NJ, Rand KD (2016) A simple sheathless CE-MS interface with a sub-micrometer electrical contact fracture for sensitive analysis of peptide and protein samples. Anal Chim Acta 936:157-167.
Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Hashi K, Ohtaki S, . . . Honmou O (2016) Biological relevance of tissue factor and IL-6 in arteriovenous malformations. Neurosurg Rev.
Rojas S, Herance JR, Gispert JD, Arias B, Miquel I, Lopez R, . . . Murat J (2016) Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F. Eur J Drug Metab Pharmacokinet.
Sadeghi N, Iacobelli M, Vaziri B, Kahn D, Hoppensteadt D, Guler N, Fareed J (2016) Recombinant Factor VIIa-Mediated Activation of Prothrombin Complex Concentrates: Studies on the Comparison of NovoSeven With a Biosimilar Product. Clin Appl Thromb Hemost.
Scholl A, Ivanov I, Hinz B (2016) Inhibition of interleukin-1beta-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2. Oncotarget.
Spiezia L, Campello E, Valle FD, Woodhams B, Simioni P (2016) Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation. Clin Chem Lab Med.
Yi L, Huang X, Guo F, Zhou Z, Dou Y, Huan J (2016) Yes-associated protein (YAP) signaling regulates lipopolysaccharide-induced tissue factor expression in human endothelial cells. Surgery 159:1436-1448.
Zeybek B, Childress AM, Kilic GS, Phelps JY, Pacheco LD, Carter MA, Borahay MA (2016) Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach. Obstet Gynecol Surv 71:488-500.
Zhang Z, Hu L, Chen W, Zhou C, Gui G, Lin B (2016) Danhong huayu koufuye prevents deep vein thrombosis through anti-inflammation in rats. J Surg Res 201:340-347.
_________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
_________________________________
